News
Brensocatib reduces exacerbations in bronchiectasis: WILLOW study
A novel anti-inflammatory treatment for bronchiectasis that targets neutrophils has shown promising results in a phase 2 trial. In findings presented at ATS 2020 virtual meeting, ...
Read More →
Vitamin D Deficiency
Vitamin D deficiency is common in adults with bronchiectasis and may be linked to radiological findings indicative of poor lung function, a study reports. The study, “Vitamin D ...
Read More →
LFA Action Plan
Lung Foundation Australia have recently updated their bronchiectasis action plan. This can be downloaded from: LFA Bronchiectasis Action Plan
Read More →
COVID 19 Resources from LFA
Lung Foundation Australia have excellent COVID 19 resources on their website collated from information provided by the Australian Government Department of Health and leading respiratory ...
Read More →
COVID-19 and Bronchiectasis
Interview with Infectious diseases expert, Prof James Chalmers. Patient: I am a patient with bronchiectasis. Am I at more risk of getting COVID-19 than somebody ...
Read More →
Epidemiology of bronchiectasis in the UK: Findings from the British lung foundation’s ‘Respiratory health of the nation’ projec
A recent paper in Respiratory Medicine has shown that the prevalence and incidence of bronchiectasis in the UK is increasing, with a 3% increase in ...
Read More →
Six ways that bronchiectasis treatment is at odds with guidelines
Results from the Australian Bronchiectasis Registry (ABR) show a gap between guideline recommendations and real-world treatment of bronchiectasis, even in tertiary centres. Data from 589 ...
Read More →
Respiratory physiotherapy in the bronchiectasis guidelines: is there a loud voice we are yet to hear?
Bronchiectasis is a chronic respiratory disease of airway dilatation, where patients typically suffer from respiratory infections, fatigue, sputum, cough, dyspnoea and poor quality of life ...
Read More →
Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry
The Australian Bronchiectasis Registry (ABR), established in 2015, aims to evaluate clinical phenotypes of Australians with bronchiectasis. Their first report, published in Respiratory Medicine (Australian ...
Read More →
Updated British Thoracic Society guidelines
The British Thoracic Society have updated their recommendations and clinical practice points in January 2019. Key points included are related to imaging, in whom a ...
Read More →
Updated Spanish guidelines on the treatment of bronchiectasis in adults
After publishing the first guidelines in the world on the diagnosis and management of bronchiectasis back in 2008, the Spanish Society of Pulmonology (SEPAR) have ...
Read More →
Vitamin D and bronchiectasis severity
Vitamin D is a key molecule known to be involved in inflammation and immune responses so a team of Italian researchers sought to investigate whether ...
Read More →
New Antibiotic Formulation Better at Controlling Infections in Bronchiectasis
Inhaled antibiotics have been proposed as efficient treatments to reduce bacterial infections in bronchiectasis patients. Now researchers have shown that a new formulation of antibiotics using nanoparticles, called nanoplex, ...
Read More →
ERS Monograph: Bronchiectasis
The latest European Respiratory Society Monograph: Bronchiectasis is now available! A team of world recognised experts in bronchiectasis have contributed to this monograph, covering topics ...
Read More →
3rd World Bronchiectasis Conference
The 3rd World Bronchiectasis conference was held in July 2018 in Georgetown, Washington DC. With a mix of world class presenters, it provided a comprehensive ...
Read More →
New Guidelines on Managing Adult Bronchiectasis
With the help of experts from the European Respiratory Society (ERS) and the bronchiectasis patient advisory group, new guidelines on the management of adult bronchiectasis ...
Read More →
COPD and bronchiectasis
A recent study published in Medical Sciences (April 2017) has shown that patients with both bronchiectasis and chronic obstructive pulmonary disease (COPD) experience more frequent ...
Read More →
Aerobika device for bronchiectasis
The Aerobika® device The Aerobika® device is hand-held, easy-to-use, and drug-free. When the patient exhales through the device, intermittent resistance creates positive pressure and oscillations simultaneously, which stabilises the ...
Read More →
Pulmonary rehabilitation for bronchiectasis
Pulmonary rehabilitation is routinely recommended for people with Chronic Obstructive Pulmonary Disease (COPD), but recent studies have highlighted that people diagnosed with bronchiectasis can also ...
Read More →
Bronchiectasis an independent risk factor for heart disease
A study using UK primary care data found pre-existing coronary heart disease (CHD) (OR 1.33, 95% CI 1.25 to 1.41) and stroke (OR 1.92, 95% ...
Read More →
World Immunisation Week
April 24th – 30th is World Immunisation week which aims to raise awareness about the importance of being immunised. Influenza and pneumonia are common lung ...
Read More →
2nd World Bronchiectasis Conference
The 2nd World Bronchiectasis Conference is being held in Milan from 6th – 8th July 2017. For further information go to – http://www.world-bronchiectasis-conference.org/
Read More →
Forced Expiration Technique
[vc_row][vc_column][vc_column_text]The forced expiration technique, if taught correctly, is possibly the most effective airway clearance technique. Watch this video to learn the correct procedure.[/vc_column_text][vc_video link=”https://vimeo.com/148582451″][/vc_column][/vc_row]
Read More →
Strong Lungs Story
[vc_row][vc_column][vc_column_text]This video, featuring Steven Motlop and Nakia Cockatoo from the Geelong Football Club, is a health message developed for the Indigenous children of Australia.[/vc_column_text][vc_video link=”https://vimeo.com/183320453″][/vc_column][/vc_row]
Read More →